Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A
Genes · 22.01.2023 · 14 (2) · 289
DOI: 10.3390/genes14020289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 22.01.2023. Verfasst von Chaten D Jessel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada. Hauptthemen laut MEDLINE: Caffeine, Receptor, Adenosine A2A. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, Alberta Innovates Summer Research Studentship.
Themen: Schlaf, Kinderkrankenpflege
Abstract (Originalsprache)
Caffeine is the most consumed drug in the world, and it is commonly used by children. Despite being considered relatively safe, caffeine can have marked effects on sleep. Studies in adults suggest that genetic variants in the adenosine A2A receptor (ADORA2A, rs5751876) and cytochrome P450 1A (CYP1A, rs2472297, rs762551) loci are correlated with caffeine-associated sleep disturbances and caffeine intake (dose), but these associations have not been assessed in children. We examined the independent and interaction effects of daily caffeine dose and candidate variants in ADORA2A and CYP1A on the sleep quality and duration in 6112 children aged 9–10 years who used caffeine and were enrolled in the Adolescent Brain Cognitive Development (ABCD) study. We found that children with higher daily caffeine doses had lower odds of reporting > 9 h of sleep per night (OR = 0.81, 95% CI = 0.74–0.88, and p = 1.2 × 10−6). For every mg/kg/day of caffeine consumed, there was a 19% (95% CI = 12–26%) decrease in the odds of children reporting > 9 h of sleep. However, neither ADORA2A nor CYP1A genetic variants were associated with sleep quality, duration, or caffeine dose. Likewise, genotype by caffeine dose interactions were not detected. Our findings suggest that a daily caffeine dose has a clear negative correlation with sleep duration in children, but this association is not moderated by the ADORA2A or CYP1A genetic variation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada.
- Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N4N1, Canada.
- Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N4N1, Canada.
- Departments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences, University of Calgary, Calgary, AB T2N4N1, Canada.
ORCID-Profile: Chad A Bousman
Förderung
- NIDA NIH HHS
- Alberta Innovates Summer Research Studentship
Zitieren
APA
Jessel, C. D., Narang, A., Zuberi, R., & Bousman, C. A. (2023). Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A. Genes, 14(2), 289. https://doi.org/10.3390/genes14020289
Vancouver
Jessel CD, Narang A, Zuberi R, Bousman CA. Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A. Genes. 2023;14(2):289. doi:10.3390/genes14020289
BibTeX
@article{Jessel2023,
author = {Jessel, Chaten D and Narang, Ankita and Zuberi, Rayyan and Bousman, Chad A},
title = {Sleep Quality and Duration in Children That Consume Caffeine: Impact of Dose and Genetic Variation in ADORA2A and CYP1A},
journal = {Genes},
year = {2023},
volume = {14},
number = {2},
pages = {289},
doi = {10.3390/genes14020289}
}
EUVIMED